Kim Jong Joseph

Chief Executive Officer

C-suiteM

US·SEC (Form 4)

Inovio Pharmaceuticals, INC.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Discover the detailed record of transactions filed by Kim Jong Joseph, Chief Executive Officer. Officer active across 1 companies, notably Inovio Pharmaceuticals, INC.. In total, 3 filings have been published. Regulator: SEC (Form 4). The full history is accessible without signup.

Declarations3 total

Executives◇OptionsIInovio Pharmaceuticals, INC.26SEC

K

Kim Jong JosephChief Executive Officer

139,387 shares

Common Stock

SEC:0001055726-22-000020:0·11 Mar 2022

SEC ↗

Executives◇OptionsIInovio Pharmaceuticals, INC.26SEC

K

Kim Jong JosephChief Executive Officer

63,700 shares

Common Stock

SEC:0001055726-22-000016:0·8 Mar 2022

SEC ↗

Executives◇OptionsIInovio Pharmaceuticals, INC.26SEC

K

Kim Jong JosephChief Executive Officer

68,767 shares

Common Stock

SEC:0001055726-22-000009:0·26 Feb 2022

SEC ↗

3 of 3 declarations

About Kim Jong Joseph

Kim Jong Joseph is the Chief Executive Officer of INOVIO PHARMACEUTICALS, INC. He is responsible for the strategic and operational leadership of the company, ensuring performance objectives are met and innovation in pharmaceutical products is achieved.